Search Results 211-220 of 859 for NDC

  1. Publications - Nneka I. Comfere, M.D. - Mayo Clinic

    Lehman JS, Mohandesi NA, Agrawal S, Camilleri MJ, Cervenka DJ, Comfere NI, Johnson EF, Kalaaji AN, Lange CR, Shore CJ, Smith P, Wieland CN, ...

  2. Donor-derived Cell-free DNA Testing in Kidney Transplant Recipients on Reduced Immunosuppression - Mayo Clinic

    About this study. The purpose of this study is to determine the incidence of biopsy proven acute rejections detected due to elevated dd-cfDNA independent of ...

  3. A Study Of Belantamab Mafodotin Administered In Combination With Lenalidomide And Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, And Dexamethasone (DRd) In Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible For Autologous Stem Cell Transplantation (TI-NDMM) - Mayo Clinic

    The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status ...

  4. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  6. Publications - Andrea N. Leep Hunderfund, M.D., M.H.P.E. - Mayo Clinic

    O'Sullivan CC, Jenkins S, Leep Hunderfund AN, Ruddy KJ, West CP, Marshall AL. Spousal Support and Physician Work-Life Integration and Burnout.

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  8. Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - Mayo Clinic

    The purpose of this study is to assess the efficacy of paltusotine vs placebo in reducing flushing episodes. Participation eligibility. Participant eligibility ...

  9. Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) - Mayo Clinic

    Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, ...

  10. Publications

    Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...